Back to search
Neurotrophic Corneal Ulcer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurotrophic Corneal Ulcer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurotrophic Corneal Ulcer trials you may qualify forPrimary Objective: To assess the efficacy of cenegermin-bkbj (20 mcg/mL) ophthalmic solution on overall corneal thickness via AS-OCT in patients with stage 3 n…
This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor (rhNGF) eye drops solution compared t…
Neurotrophic keratitis (NK) is a condition where the cornea, or clear outer covering of the eye, has reduced sensation due to a variety of reasons. In more adva…
To evaluate Safety and efficacy of topical insulin in treatment of neurotrophic corneal ulcers
Various treatment options have been proposed in managing NK such as preservative-free lubrication (PF-L), withdrawal of epitheliotoxic medication, prophylactic…
The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotr…
Purpose: To evaluate the clinical outcome of patients with refractory Neurotrophic Keratopathy (NK) in stages 2 and 3 treated with topical insulin. Methods: A…
The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a demyelinating chronic progressive or relapsing neuropathy believed to be secondary to an a…